소아 메밀 알레르기 환자에서 특이항체와 임상증상과의 상관성
Clinical and laboratory findings of childhood buckwheat allergy in a single tertiary hospital
- 주제(키워드) Anaphylaxis , Hypersensitivity , Buckwheat , Child
- 발행기관 아주대학교
- 지도교수 이수영
- 발행년도 2017
- 학위수여년월 2017. 2
- 학위명 석사
- 학과 및 전공 일반대학원 의학과
- 실제URI http://www.dcollection.net/handler/ajou/000000024133
- 본문언어 영어
- 저작권 아주대학교 논문은 저작권에 의해 보호받습니다.
초록/요약
Purpose Although buckwheat allergy is one of the most severe food allergies in some countries, especially in children, few studies have investigated this condition. The aim of this study was to report clinical and laboratory findings of buckwheat allergy in Korean children. Methods Thirty-seven subjects, aged 1 to 14 years, were enrolled by retrospective medical record review from January 2000 through May 2015 at the Department of Pediatrics in Ajou University Hospital. Demographic profiles, previous exposure to buckwheat pillows, clinical symptoms, and laboratory findings were recorded. Results Twenty-six out of 37 children had immediate-type allergic symptoms to buckwheat, while 11 subjects were tolerant to buckwheat. Seventeen (65.4%) out of 26 buckwheat allergic children had anaphylaxis. The median buckwheat specific immunoglobulin E level in the buckwheat allergic group (7.71 kUA/L) was significantly higher (P<0.001) than that in the buckwheat tolerant group (0.08 kUA/L) with an optimal cut-off value of 1.27 kUA/L (sensitivity 84.6%, specificity 100%). When adjusted for age between two groups, the difference showed borderline significance (P=0.063). In subjects who had anaphylaxis, buckwheat-specific immunoglobulin E levels ranged from 0.37 kUA/L to 100 kUA/L. Conclusion Almost two-thirds of buckwheat-allergic children had anaphylaxis. Amongst these children, a wide-range of buckwheat specific immunoglobulin E levels were observed. Anaphylaxis occurred in a subject with a remarkably low level of immunoglobulin E (0.37 kUA/L).
more목차
Ⅰ. Introduction ‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧ 1
Ⅱ. Materials and methods
ⅰ. Subjects‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧ 2
ⅱ. Measurement of the total IgE and specific IgE antibody levels‧‧‧‧‧‧ 2
ⅲ. Statistical analysis‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧ 2
Ⅲ. Results ‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧3
Ⅳ. Discussion ‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧5
Ⅴ. Conflict of interest ‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧ 7
Ⅵ. References ‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧ 8
Ⅶ. Tables and Figures‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧‧ 10
